Generalized epilepsy is characterized by recurrent seizures caused by oscillatory neuronal firing throughout thalamocortical networks. Current therapeutic approaches often intervene at the level of the thalamus or cerebral cortex to ameliorate seizures. We review here the therapeutic potential of cerebellar stimulation. The cerebellum forms a prominent ascending input to the thalamus and, whereas stimulation of the foliated cerebellar cortex exerts inconsistent results, stimulation of the centrally located cerebellar nuclei (CN) reliably stops generalized seizures in experimental models. Stimulation of this area indicates that the period of stimulation with respect to the phase of the oscillations in thalamocortical networks can optimize its effect, opening up the possibility of developing on-demand deep brain stimulation (DBS) treatments.
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Neurostimulation for Drug-Resistant Epilepsy
Epilepsy, defined as the occurrence of recurrent, unprovoked seizures, is one of the most common neurological disorders, affecting approximately 65 million people worldwide [1, 2] . The disorder can have devastating effects on one's life, not only directly as a result of clinical effects, which may include injury and hospitalization, but also due to socioeconomic effects such as social isolation, stigmatization, educational difficulties, and unemployment. These various consequences of epilepsy result in high comorbidity with psychiatric disorders and increased suicide rate [3] . Anti-epileptic drugs (AEDs), which induce considerable side effects, provide a decrease in seizure occurrence of more than 50% in $70% of epilepsy patients [2] [3] [4] [5] . In the remaining 30% of patients the next line of treatment is often invasive. If the focus (or foci) of the seizures can be localized, and if the tissue involved is accessible and non-eloquent (see Glossary), patients can be treated by neurosurgical resection [6] . If patients cannot be operated upon or show refractory epilepsy following resection, they are potential candidates for neurostimulation. This class comprises $30% of the medication-resistant cases.
Selecting the optimal stimulation target to treat these severely affected patients is a challenging task. However, the current surge of data from various clinical trials on the impact of vagal nerve stimulation (VNS) and deep brain stimulation (DBS) in the thalamus or epileptic focus reveals that, specific neurostimulation paradigms have therapeutic value for various types of drug-resistant epilepsies (Box 1). Moreover, recent experimental evidence indicates that neurostimulation of the cerebellum can have potential therapeutic benefits [7, 8] . In contrast to the cerebellar cortex, which has been probed for treatment of epilepsy since the dawn of DBS [9] , the CN have rarely been targeted for seizure control in epilepsy patients [10, 11] . However, the CN are in a key position to affect a wide range of thalamic nuclei (Box 2) and can therefore, in our opinion, be of potential therapeutic interest for the treatment of particular types of epilepsy. In the current review, we address why the CN should be targeted and how the impact of the CN on thalamocortical networks should be studied in experimental epilepsy models. We aim to provoke a re-evaluation of the potential use of cerebellar neurostimulation to stop epileptic seizures.
Trends
Electrical neurostimulation is commonly applied in patients with drugresistant epilepsy, but the optimal stimulation sites for each of the type of seizures remain to be identified and may be outside the epileptic focus.
The most important issues for identifying the optimal stimulation site are its anatomical connections, its impact on the neuronal spiking patterns of downstream targets when stimulated, and its accessibility.
Emerging data from optogenetic studies in mouse models of various epilepsies indicate that controlling the cerebellar output can be effectively used to stop several types of seizures.
By selectively increasing or decreasing the spiking activity of CN neurons, the firing of downstream neurons in thalamocortical networks can be efficiently modulated so as to disrupt epileptic activity. 
